Literature DB >> 12397142

Relation between medial temporal atrophy and functional brain activity during memory processing in Alzheimer's disease: a combined MRI and SPECT study.

G E J Garrido1, S S Furuie, C A Buchpiguel, C M C Bottino, O P Almeida, C G Cid, C H P Camargo, C C Castro, M F Glabus, G F Busatto.   

Abstract

OBJECTIVE: To investigate the relation between atrophy of the hippocampal region and brain functional patterns during episodic memory processing in Alzheimer's disease. PATIENTS AND METHODS: Whole brain structural magnetic resonance imaging (MRI) data and single photon emission computed tomography (SPECT) measures of regional cerebral blood flow (rCBF) were obtained during a verbal recognition memory task in nine subjects with mild Alzheimer's disease and 10 elderly healthy controls. Using the statistical parametric mapping approach, voxel based comparisons were made on the MRI data to identify clusters of significantly reduced grey matter concentrations in the hippocampal region in the Alzheimer patients relative to the controls. The mean grey matter density in the voxel cluster of greatest hippocampal atrophy was extracted for each Alzheimer subject. This measure was used to investigate, on a voxel by voxel basis, the presence of significant correlations between the degree of hippocampal atrophy and the rCBF SPECT measures obtained during the memory task.
RESULTS: Direct correlations were detected between the hippocampal grey matter density and rCBF values in voxel clusters located bilaterally in the temporal neocortex, in the left medial temporal region, and in the left posterior cingulate cortex during the memory task in the Alzheimer's disease group (p < 0.001). Conversely, measures of hippocampal atrophy were negatively correlated with rCBF values in voxel clusters located in the frontal lobes, involving the right and left inferior frontal gyri and the insula (p < 0.001).
CONCLUSIONS: Hippocampal atrophic changes in Alzheimer's disease are associated with reduced functional activity in limbic and associative temporal regions during episodic memory processing, but with increased activity in frontal areas, possibly on a compensatory basis.

Entities:  

Mesh:

Year:  2002        PMID: 12397142      PMCID: PMC1738103          DOI: 10.1136/jnnp.73.5.508

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  51 in total

1.  Cholinergic stimulation alters performance and task-specific regional cerebral blood flow during working memory.

Authors:  M L Furey; P Pietrini; J V Haxby; G E Alexander; H C Lee; J VanMeter; C L Grady; U Shetty; S I Rapoport; M B Schapiro; U Freo
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

2.  Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging.

Authors:  C C Meltzer; J K Zubieta; J Brandt; L E Tune; H S Mayberg; J J Frost
Journal:  Neurology       Date:  1996-08       Impact factor: 9.910

3.  Quantitative magnetic resonance imaging and neuropsychological functions in dementia of the Alzheimer type.

Authors:  J Pantel; J Schröder; L R Schad; M Friedlinger; M V Knopp; R Schmitt; M Geissler; S Blüml; M Essig; H Sauer
Journal:  Psychol Med       Date:  1997-01       Impact factor: 7.723

4.  Regional cerebral blood flow (rCBF) in schizophrenia during verbal memory activation: a 99mTc-HMPAO single photon emission tomography (SPET) study.

Authors:  G F Busatto; D C Costa; P J Ell; L S Pilowsky; A S David; R W Kerwin
Journal:  Psychol Med       Date:  1994-05       Impact factor: 7.723

Review 5.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

6.  Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: correlation with memory functions.

Authors:  M P Laakso; H Soininen; K Partanen; E L Helkala; P Hartikainen; P Vainio; M Hallikainen; T Hänninen; P J Riekkinen
Journal:  J Neural Transm Park Dis Dement Sect       Date:  1995

7.  High-resolution SPECT to assess hippocampal perfusion in neuropsychiatric diseases.

Authors:  T Ohnishi; H Hoshi; S Nagamachi; S Jinnouchi; L G Flores; S Futami; K Watanabe
Journal:  J Nucl Med       Date:  1995-07       Impact factor: 10.057

8.  Comparisons of verbal fluency tasks in the detection of dementia of the Alzheimer type.

Authors:  A U Monsch; M W Bondi; N Butters; D P Salmon; R Katzman; L J Thal
Journal:  Arch Neurol       Date:  1992-12

9.  A single photon emission computerised tomography study of regional brain function underlying verbal memory in patients with Alzheimer-type dementia.

Authors:  W Riddle; R E O'Carroll; N Dougall; M Van Beck; C Murray; S M Curran; K P Ebmeier; G M Goodwin
Journal:  Br J Psychiatry       Date:  1993-08       Impact factor: 9.319

10.  Compensatory reallocation of brain resources supporting verbal episodic memory in Alzheimer's disease.

Authors:  J T Becker; M A Mintun; K Aleva; M B Wiseman; T Nichols; S T DeKosky
Journal:  Neurology       Date:  1996-03       Impact factor: 9.910

View more
  27 in total

1.  Memory-provoked rCBF-SPECT as a diagnostic tool in Alzheimer's disease?

Authors:  Torbjörn Sundström; Eva Elgh; Anne Larsson; Birgitta Näsman; Lars Nyberg; Katrine A Riklund
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-09-09       Impact factor: 9.236

2.  Functional connectivity changes differ in early and late-onset Alzheimer's disease.

Authors:  Natalina Gour; Olivier Felician; Mira Didic; Lejla Koric; Claude Gueriot; Valérie Chanoine; Sylviane Confort-Gouny; Maxime Guye; Mathieu Ceccaldi; Jean Philippe Ranjeva
Journal:  Hum Brain Mapp       Date:  2013-10-05       Impact factor: 5.038

3.  Rhinal hypometabolism on FDG PET in healthy APO-E4 carriers: impact on memory function and metabolic networks.

Authors:  Mira Didic; Olivier Felician; Natalina Gour; Rafaelle Bernard; Christophe Pécheux; Olivier Mundler; Mathieu Ceccaldi; Eric Guedj
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-04-22       Impact factor: 9.236

4.  Sequential relationships between grey matter and white matter atrophy and brain metabolic abnormalities in early Alzheimer's disease.

Authors:  Nicolas Villain; Marine Fouquet; Jean-Claude Baron; Florence Mézenge; Brigitte Landeau; Vincent de La Sayette; Fausto Viader; Francis Eustache; Béatrice Desgranges; Gaël Chételat
Journal:  Brain       Date:  2010-08-05       Impact factor: 13.501

5.  Brain perfusion correlates of medial temporal lobe atrophy and white matter hyperintensities in mild cognitive impairment.

Authors:  Anna Caroli; Cristina Testa; Cristina Geroldi; Flavio Nobili; Ugo P Guerra; Matteo Bonetti; Giovanni B Frisoni
Journal:  J Neurol       Date:  2007-03-20       Impact factor: 4.849

Review 6.  Neurotoxic saboteurs: straws that break the hippo's (hippocampus) back drive cognitive impairment and Alzheimer's Disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2013-07-03       Impact factor: 3.911

Review 7.  Overlapped metabolic and therapeutic links between Alzheimer and diabetes.

Authors:  Waqar Ahmad
Journal:  Mol Neurobiol       Date:  2012-09-26       Impact factor: 5.590

8.  L-arginine and Alzheimer's disease.

Authors:  Jing Yi; Laura L Horky; Avi L Friedlich; Ying Shi; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Pathol       Date:  2008-10-02

9.  Vascular health risks and fMRI activation during a memory task in older adults.

Authors:  Meredith N Braskie; Gary W Small; Susan Y Bookheimer
Journal:  Neurobiol Aging       Date:  2008-10-01       Impact factor: 4.673

10.  Effects of medial temporal lobe degeneration on brain perfusion in amnestic MCI of AD type: deafferentation and functional compensation?

Authors:  Eric Guedj; Emmanuel J Barbeau; Mira Didic; Olivier Felician; Catherine de Laforte; Jean-Philippe Ranjeva; Michel Poncet; Patrick J Cozzone; Olivier Mundler; Mathieu Ceccaldi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-02-18       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.